Invo Bioscience Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
INVO Nasdaq 3841 https://invobioscience.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Invo Bioscience Inc

INVO Provides Preliminary Update on FY2022 Financial Results - Mar 30th, 2023 9:25 pm
INVO Bioscience Announces Closing of $3.0 Million Registered Direct Offering - Mar 27th, 2023 9:06 pm
INVO Bioscience Announces Pricing of $3.0 Million Registered Direct Offering Priced At-The-Market - Mar 24th, 2023 12:00 pm
INVO Signs Binding Agreements to Acquire Wisconsin Fertility Institute - Mar 20th, 2023 1:00 pm
INVO Bioscience Enters Distribution Agreement for Taiwan - Jan 5th, 2023 2:00 pm
INVO Bioscience Engages Nationally Recognized Physician for New Tampa-based INVO Center - Jan 3rd, 2023 2:00 pm
First Baby Born in Malaysia Utilizing Innovative INVOcell Assisted Reproductive Technology - Nov 30th, 2022 2:30 pm
INVO Bioscience Reports Third Quarter 2022 Financial Results - Nov 14th, 2022 9:05 pm
INVO Bioscience to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022 - Nov 10th, 2022 9:15 pm
INVO Bioscience Highlights INVOcell Progress From the 2022 American Society for Reproductive Medicine (ASRM) Congress & Expo - Nov 1st, 2022 1:00 pm
INVOcell Review Published in Current Opinion in Obstetrics and Gynecology - Oct 21st, 2022 1:00 pm
INVO Bioscience to Exhibit at the 2022 American Society for Reproductive Medicine (ASRM) Congress & Expo - Oct 17th, 2022 1:00 pm
Dr. Sue Ellen Carpenter of INVO Bioscience's Atlanta-based INVO Center - Bloom Fertility - Named Top Doctor by Castle Connolly - Sep 22nd, 2022 1:00 pm
INVOcell Launched in Malaysia by Advanced Reproductive Centre, Hospital Canselor Tuanku Muhriz - Aug 25th, 2022 1:00 pm
INVO Bioscience Reports Second Quarter 2022 Financial Results - Aug 15th, 2022 8:05 pm
INVO Bioscience to Report Second Quarter 2022 Financial Results on Monday, August 15, 2022 - Aug 4th, 2022 8:15 pm
INVO Bioscience Announces "Get to Know INVOcell" - a Series of Facebook Live Events Supporting Access to Affordable Fertility Treatment - Jul 7th, 2022 12:00 pm
INVO Signs Distribution Agreement with Onesky Holding Limited for Mainland China - May 16th, 2022 8:15 pm
INVO Bioscience Reports First Quarter 2022 Financial Results - May 16th, 2022 8:05 pm
INVO Bioscience to Report First Quarter 2022 Financial Results on Monday, May 16, 2022 - May 9th, 2022 8:30 pm